Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Chelsea Therapeutics International Reports Q3 EPS $-0.09 vs $-0.11 Est

Paul Quintaro, Benzinga Staff Writer
November 07, 2012 6:08 PM
+ Follow
Print
Email
Tickers: CHTP
Benzinga Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS

Posted in: Earnings, News

 

Around the Web, We're Loving...

Obama Taking Action on Gun Background Check System
One Boston Suspect Dead, Police Search For Second
Can Netflix Be a Blockbuster Again? Click here to access an exclusive research report on NFLX from The Motley Fool

Most Popular

UPDATE: J.P. Morgan Downgrades Apache Corporation to Neutral on Lack of Catalysts, Low Growth
UPDATE: Credit Suisse Raises PT on SanDisk Corporation on Solid March Results, June Guidance
Boeing Dreamliner May Fly Soon
Is Apple Shifting New iMac Production to the United States?
Should Google's Vic Gundotra Become Microsoft's New CEO?
What to Expect from Google's Earnings

Related Articles (CHTP)

Benzinga's Small Cap Movers for Wednesday February 20, 2013
Market Wrap for Wednesday February 20: Stocks Fall as Risks Re-Emerge; VIX up 19%
UPDATE: Wedbush Reiterates Outperform Rating, Raises PT on Chelsea Therapeutics International on Successful Appeal
Benzinga's Top Pre-Market Gainers
FDA Issues Guidance for Chelsea Therapeutics' Northera, to Resubmit NDA in Late Q2, Says ST Benefit Enough to Support Okay

Partner Network

Get Benzinga's News Delivered Free

Posts by Paul Quintaro

Benzinga Professional

Subscribe